Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 2. Effects of calcium supplements on serum total calcium concentration in normal postmenopausal women. (A) The calcaemic effects of calcium (500 mg)

Published byJoella Floyd Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 2. Effects of calcium supplements on serum total calcium concentration in normal postmenopausal women. (A) The calcaemic effects of calcium (500 mg)"— Presentation transcript:

1 Fig. 2. Effects of calcium supplements on serum total calcium concentration in normal postmenopausal women. (A) The calcaemic effects of calcium (500 mg) as citrate administered fasting (closed circles) are contrasted with those of a dairy product meal with the same calcium content. (B) The calcaemic effects of calcium (500 mg) as citrate are contrasted when administered fasting (closed circles) or with a meal (open circles). (C) The calcaemic effects of 1 g calcium as citrate is shown at baseline in calcium-naive women (closed circles) or after 3 months of daily use of a 1 g calcium supplement (open circles). Adapted from Bristow et al., with permission from Cambridge University Press [34, 36]. aSignificantly different from citrate-fasting (P<0.05). Fig. 2. Effects of calcium supplements on serum total calcium concentration in normal postmenopausal women. (A) The calcaemic effects of calcium (500 mg) as citrate administered fasting (closed circles) are contrasted with those of a dairy product meal with the same calcium content. (B) The calcaemic effects of calcium (500 mg) as citrate are contrasted… Endocrinol Metab Sep;32(3):

Download ppt "Fig. 2. Effects of calcium supplements on serum total calcium concentration in normal postmenopausal women. (A) The calcaemic effects of calcium (500 mg)"

Similar presentations

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
Cinnamon: Not Your Grandma’s Spice Anymore Christie Seibert, MD Primary Care Conference May 14, 2008.

Cinnamon: Not Your Grandma’s Spice Anymore Christie Seibert, MD Primary Care Conference May 14, 2008.
THE EFFECTS OF INTERMITTENT VITAMIN D3 SUPPLEMENTATION ON MUSCLE STRENGHT AND METABOLIC PARAMETERS IN POSTMENOPAUSAL WOMEN WITH TYPE 2 BIABETES: A RANDOMIZED.

THE EFFECTS OF INTERMITTENT VITAMIN D3 SUPPLEMENTATION ON MUSCLE STRENGHT AND METABOLIC PARAMETERS IN POSTMENOPAUSAL WOMEN WITH TYPE 2 BIABETES: A RANDOMIZED.
Chapter 28 Chapter 28 Nutrition and Risk for Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.

Chapter 28 Chapter 28 Nutrition and Risk for Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 72 Chapter 72 Calcium in the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.

Chapter 72 Chapter 72 Calcium in the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
© Cambridge University Press 2013 Thomson_alphaem.

© Cambridge University Press 2013 Thomson_alphaem.
© Cambridge University Press 2013 Thomson_Fig-1-1-1.

© Cambridge University Press 2013 Thomson_Fig
GLP-1 Effectiveness, Mechanisms of Action and Potential Part 2.

GLP-1 Effectiveness, Mechanisms of Action and Potential Part 2.
© Cambridge University Press 2013 Thomson_Fig-14-2-1.

© Cambridge University Press 2013 Thomson_Fig
Compare and Contrast.

Compare and Contrast.
Follicle-Stimulating Hormone Induces Postmenopausal Dyslipidemia Through Inhibiting Hepatic Cholesterol Metabolism J Clin Endocrinol Metab 101: 254–263,

Follicle-Stimulating Hormone Induces Postmenopausal Dyslipidemia Through Inhibiting Hepatic Cholesterol Metabolism J Clin Endocrinol Metab 101: 254–263,
Osteopenia and Osteoporosis

Osteopenia and Osteoporosis
Figure 2. Summary of trial events

Figure 2. Summary of trial events
Fig. 1. The cumulative incidence of diabetic complication in middle-age-onset and elderly-onset diabetes. (A) Cumulative incidence (%) of coronary revascularization.

Fig. 1. The cumulative incidence of diabetic complication in middle-age-onset and elderly-onset diabetes. (A) Cumulative incidence (%) of coronary revascularization.
Fig. 1. Baseline and 3-month infusion protocol

Fig. 1. Baseline and 3-month infusion protocol
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis  Peyman Hadji  Critical Reviews in Oncology.

Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis  Peyman Hadji  Critical Reviews in Oncology.
Fig. 1. Mean BMI and BMI Z-score (se) of the children with AA, TA, and TT genotypes in rs9939609 of the FTO gene. The P values are for the additive model.

Fig. 1. Mean BMI and BMI Z-score (se) of the children with AA, TA, and TT genotypes in rs of the FTO gene. The P values are for the additive model.
© Cambridge University Press 2011

© Cambridge University Press 2011
Figure 1. Illustrative 24-h serum LH concentration (IRMA) profiles and calculated LH secretory rates as determined by deconvolution analysis in one healthy.

Figure 1. Illustrative 24-h serum LH concentration (IRMA) profiles and calculated LH secretory rates as determined by deconvolution analysis in one healthy.
Fig. 1. Intravenous glucose infusion rates during an isoglycemic intravenous glucose infusion (IIGI) study in subjects with (A) normal glucose tolerance.

Fig. 1. Intravenous glucose infusion rates during an isoglycemic intravenous glucose infusion (IIGI) study in subjects with (A) normal glucose tolerance.

Similar presentations

Ads by Google